Inventor

Yen-Ming Hsu

Inventor
Lexington, MA, US

Overview

24→
Patents
1997–2016
Patent span
Chemistry
Primary field (CPC C)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides33%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
C12NMicroorganisms or enzymes5%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
F25BRefrigeration machines, plants or systems2%
H01LSemiconductor devices2%
PatentTitleYear
9,494,597'Human control antibodies and uses therefor'20169,321,840'Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof'20169,297,810'CD40L-binding agent based platelet aggregation assays'20169,276,164'Optoelectronic device and method for manufacturing the same'20169,097,726'Methods of evaluating BAFF'20159,034,324'Anti-BCMA antibodies'20158,821,883'Method of treating B cell cancers by administering truncated BAFF receptors'20148,784,823'Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof'20148,685,657'Methods of evaluating BAFF'20148,617,545'Methods for use with BAFF antagonists'20138,415,111'Methods of evaluating BAFF'20138,409,810'Platelet aggregation assays using a CD40L-binding agent'20138,303,958'Method of treating immunological disorders by administering truncated BAFF receptors'20128,293,237'Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof'20128,202,698'Methods of evaluating BAFF'20128,022,182'Truncated BAFF receptors'20117,700,317'Truncated baff receptors'20107,173,046'CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications'20077,087,390'CAIP-like gene family'20066,423,824'CAIP-like gene family'20026,171,800'Method of making and binding CAIP polypeptides'20015,837,844'CAIP-like gene family'19985,656,438'CAIP-like gene family'19975,641,748'Caip-like gene family'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2007Patents assigned to BIOGEN INC (6)· patent assignee history
1997–2016Based in Lexington, MA, US· patent location history
2006–2016Patents assigned to BIOGEN IDEC INC (16)· patent assignee history
2012–2015Patents assigned to HSU YEN-MING (7)· patent assignee history
2012–2015Patents assigned to KALLED SUSAN L (4)· patent assignee history
2015–2016Patents assigned to BIOGEN MA INC (3)· patent assignee history
2016Based in Hsinchu, TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOGEN IDEC INC162006–2016
HSU YEN-MINGself72012–2015
BIOGEN INC61997–2007
KALLED SUSAN L42012–2015
BIOGEN MA INC32015–2016
Locations
LocationPatentsSpan
Lexington, Massachusetts, US231997–2016
Hsinchu, TW12016